On June 24, 2022, a radical far-right majority on the U.S. Supreme Court overturned Roe v. Wade and denied the constitutional right to abortion in Dobbs v. Jackson Women’s Health Organization. This decision propelled the country into a state of confusion where currently, 14 states have abortion bans in place at any point in pregnancy, and many others have additional, severe bans. The Dobbs decision resulted in waves of legal and legislative challenges across the country aimed both to expand access to abortion as well as to eradicate it. All the while, extremist lawmakers have brazenly attempted to politicize drug safety and the judiciary in one fell swoop to eliminate access to medication abortion in the case of the Alliance for Hippocratic Medicine v. the U.S. Food and Drug Administration (FDA). That litigation has the potential to eliminate access to mifepristone—one of the drugs used in the two-step regimen for abortion care and miscarriage treatment—across the country.
The above excerpt was originally published in the Center for American Progress.
Click here to view the story collection